DOCSLIB.ORG

Series Editors Editorial Board

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Series Editors Editorial Board SERIES EDITORS D. ROLLINSON S. I. HAY Department of Zoology, Spatial Epidemiology and Ecology Group, The Natural History Museum, London, UK Tinbergen Building, Department of [email protected] Zoology, University of Oxford, South Parks Road, Oxford, UK [email protected] EDITORIAL BOARD M. G. BASÁÑEZ R. E. SINDEN Reader in Parasite Epidemiology, Immunology and Infection Section, Department of Infectious Disease Department of Biological Sciences, Epidemiology Faculty of Medicine Sir Alexander Fleming Building, Imperial (St Mary’s campus), Imperial College, College of Science, Technology and London, London, UK Medicine, London, UK S. BROOKER D. L. SMITH Wellcome Trust Research Fellow and Johns Hopkins Malaria Research Professor, London School of Hygiene and Institute & Department of Epidemiology, Tropical Medicine, Faculty of Infectious Johns Hopkins Bloomberg School of Public and Tropical, Diseases, London, UK Health, Baltimore, MD, USA R. B. GASSER R. C. A. THOMPSON Department of Veterinary Science, Head, WHO Collaborating Centre for The University of Melbourne, Parkville, the Molecular Epidemiology of Parasitic Victoria, Australia Infections, Principal Investigator, Environmental Biotechnology CRC N. HALL (EBCRC), School of Veterinary and School of Biological Sciences, Biomedical Sciences, Murdoch University, Biosciences Building, University of Murdoch, WA, Australia Liverpool, Liverpool, UK X. N. ZHOU R. C. OLIVEIRA Professor, Director, National Institute of Centro de Pesquisas Rene Rachou/ Parasitic Diseases, Chinese Center for CPqRR - A FIOCRUZ em Minas Gerais, Disease Control and Prevention, Shanghai, Rene Rachou Research Center/CPqRR - People’s Republic of China The Oswaldo Cruz Foundation in the State of Minas Gerais-Brazil, Brazil VOLUME EIGHTY ONE AdvAnces in PARASITOLOGY Edited by S. I. HAY Spatial Epidemiology and Ecology Group Tinbergen Building, Department of Zoology, University of Oxford, South Parks Road, Oxford, UK RIC PRICE Centre of Tropical Medicine, University of Oxford, Oxford, UK J. KEVIN BAIRD Eijkman-Oxford Clinical Research Unit Jalan Diponegoro No. 69 Jakarta, Indonesia AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, UK 32 Jamestown Road, London NW1 7BY, UK Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands 225 Wyman Street, Waltham, MA 02451, USA 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA First edition 2013 Copyright © 2013 Elsevier Ltd. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by anymeans electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material. Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. ISBN: 978-0-12-407826-0 ISSN: 0065-308X For information on all Academic Press publications visit our website at www.store.elsevier.com Printed and bound in UK 13 14 15 10 9 8 7 6 5 4 3 2 1 CONTRIBUTORS Myriam Arevalo-Herrera Caucaseco Research Center, Cali, Colombia J. Kevin Baird Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK John W. Barnwell Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Malaria Branch, Division of Parasitic Diseases and Malaria, Atlanta, Georgia, USA Katherine E. Battle Department of Zoology, University of Oxford, Oxford, UK Jane M. Carlton Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA William E. Collins Institutional Association: Malaria Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia Aparup Das Evolutionary Genomics and Bioinformatics Laboratory, Division of Genomics and Bioinformatics, National Institute of Malaria Research (ICMR), Dwarka, New Delhi, India Ananias A. Escalante Center for Evolutionary Medicine and Informatics, The Biodesign Institute, Arizona State University, Tempe, AZ, USA Marcelo U. Ferreira Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo (SP), Brasil Mary R. Galinski Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, Georgia, USA; Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, USA Simon I. Hay Department of Zoology, University of Oxford, Oxford, UK Rosalind E. Howes Department of Zoology, University of Oxford, Oxford, UK ix x Contributors Christopher L. King Center of Global Health & Diseases (CGHD), Case Western Reserve University, V eterans Affairs Medical Center, Cleveland, OH, USA Odile Mercereau-Puijalon Institut Pasteur, Centre National de la Recherche Scientifique Unité de Recherche Associée, Unité d’Immunologie Moléculaire des Parasites, Paris, France Esmeralda V.S. Meyer Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, USA Ivo Mueller Walter + Eliza Hall Institute, Infection & Immunity Division, Parkville, Victoria, Australia; Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain Jean-Louis Pérignon Inserm, UMR-S 945, Paris, France; Faculté de Médecine Pitié-Salpêtrière, Université Pierre et Marie Curie-Paris 6, CHU Pitié-Salpêtrière, Paris, France; Faculté de Médecine Paris 5, Université René Descartes-Paris 5, CHU Necker-Enfants Malades, Paris, France Ari W. Satyagraha Eijkman Institute for Molecular Biology, Jakarta, Indonesia Georges Snounou Inserm, UMR-S 945, Paris, France; Faculté de Médecine Pitié-Salpêtrière, Université Pierre et Marie Curie-Paris 6, CHU Pitié-Salpêtrière, Paris, France Takafumi Tsuboi Cell-Free Science and Technology Research Center and Venture Business Laboratory, Ehime University, Matsuyama, Ehime, Japan Peter A. Zimmerman Center for Global Health & Diseases, Case Western Reserve University, Cleveland, Ohio, USA PREFACE The epidemiology of Plasmodium vivax: history, hiatus and hubris forms is a two volume special issue of Advances in Parasitology on the epidemiology of P. vivax. The aim of the review collection is to present a contemporary sum- mary of what is known about P. vivax, with the challenge set to the authors to (1) retrieve what has been ‘lost’ from ‘history’, (2) summarize objectively the current state of knowledge including the reasons for the ‘hiatus’ in inter- est and; (3) identify research gaps/directions/priorities to gently temper the prevailing ‘hubris’ with respect to control and elimination. Part A (volume 80) was published in December 2012. It was composed of six chapters and dealt principally with the most practical dimensions of vivax malaria, describing the epidemiology, clinical consequences, treat- ment, and control strategies shaped by the biology of the parasite. Part B (volume 81) is published here and brings together a further six chapters that investigate more fully aspects of the parasite life cycle, innate and inherited aspects that confer host resistance to P. vivax infection, the epidemiological importance of G6PD deficiency, what is known about the genome of P. vivax and finally the lessons that can still be learned from the interpreta- tion of the old neurosyphilis literature. Chapter 1 by Mary R. Galinski and colleagues looks in detail at the para- site’s life cycle, how it is adapted to its life history challenges and how this dif- ferentiates it from P. falciparum. They also explore the research challenges that remain in combining non-human primate models with new technologies to potentially provide further insights and epidemiological understanding of the biology of this parasite. Chapter 2, by Peter A. Zimmerman and col- leagues, reviews fascinating new complexities to what is canonically taught about red blood cell polymorphism (predominantly of the Duffy gene) and susceptibility to P. vivax infection at the individual and population levels. Chapter 3 led by Ivo Mueller reviews the natural acquisition of immunity to P. vivax. Epidemiological observations are synthesised and used to support the premise that a multi-stage P. vivax vaccine may be feasible. Chapter 4 by Rosalind E. Howes reviews the geography of G6PD deficiency. The global distribution of its prevalence and genetic variants are discussed along with the implications that this has for the potential risk of haemolysis triggered by primaquine therapy in different parts of the world. Chapter 5, written by Jane
Load more

Recommended publications
  • Texto Completo
    Ministério da Saúde Fundação Oswaldo Cruz Centro de Pesquisas René Rachou Programa de Pós-Graduação em Ciências da Saúde Estudo Molecular dos Parasitos Causadores da Malária Simiana no Centro de Primatologia do Rio de Janeiro, Brasil por Denise Anete Madureira de Alvarenga Belo Horizonte Dezembro/2014 DISSERTAÇÃO MBCM-CPqRR D.A.M. ALVARENGA 2014 Alvarenga, DAM Ministério da Saúde Fundação Oswaldo Cruz Centro de Pesquisas René Rachou Programa de Pós-Graduação em Ciências da Saúde Estudo Molecular dos Parasitos Causadores da Malária Simiana no Centro de Primatologia do Rio de Janeiro, Brasil por Denise Anete Madureira de Alvarenga Dissertação apresentada com vistas à obtenção do Título de Mestre em Ciências na área de concentração Biologia Celular e Molecular. Orientação: Dra. Cristiana Ferreira Alves de Brito Co-orientação: Dra. Taís Nóbrega de Sousa Belo Horizonte Dezembro/2014 Alvarenga, DAM II Catalogação-na-fonte Rede de Bibliotecas da FIOCRUZ Biblioteca do CPqRR Segemar Oliveira Magalhães CRB/6 1975 A473e 2014 Alvarenga, Denise Anete Madureira. Estudo Molecular dos Parasitos Causadores da Malária Simiana no Centro de Primatologia do Rio de Janeiro, Brasil / Denise Anete Madureira de Alvarenga. – Belo Horizonte, 2014. XXI, 58 f.: il.; 210 x 297mm Bibliografia: f. 70 - 77 Dissertação (mestrado) – Dissertação para obtenção do título de Mestre em Ciências pelo Programa de Pós- Graduação em Ciências da Saúde do Centro de Pesquisas René Rachou. Área de concentração: Biologia Celular e Molecular. 1. Malária Vivax/genética 2. Plasmodium vivax /imunologia 3. Reservatórios de Doenças/classificação I. Título. II. Brito, Cristiana Ferreira Alves (Orientação). III. Souza, Taís Nóbrega (Co-orientação) CDD – 22.
    [Show full text]
  • A Cross-Sectoral Approach
    A Cross-Sectoral Approach A . A£ O O e AvAg a* n e- e- o- Malaria and Development in Africa A Cross-Sectoral Approach American Association for the Advancement of Science Sub-Saharan Africa Program Under Cooperative Agreement with U.S. Agency for International Development Africa Bureau No. AFR-0481-A-00-0037-00 September 1991 Table of Contents Foreword ............................................................. v Executive Summary ....................................................ix Introduction MalariaandDevelopmentinAfrica:A Cross-SectoralApproach................ 1 Background Mala,'ia in Sub-Saharan Africa ........................................... 5 Report Recommendations ...................... ........................ 9 L Broaden Attack on Malaria by Strengthening Cross-Sectoral Cooperation for MalariaControl ..................... ...................... 11 Background ................................................ 11 Actions for National Governments .............................. 11 Actions for Donors .......................................... 13 Support Existing Cross-Sectowrl Cooperation in Sub-Saharan Africa ...13 I. Utilize Criss-SectoralApproahandResources to CombatMlaria Associated with Development Efforts .............................. 15 Potential Impact of Resource Development Projects on Malaria ............................................... 15 Example: Irrigation Development and Malaria Incidence in Zanzibar .. 15 Opportunities for Control of Malaria Associated with Development Efforts .....................................
    [Show full text]
  • E Abstracts with Advt 12.02.2019
    International Conference ee ABSTRACTSABSTRACTS Goa, 13th - 16th February, 2019 Organizers Society for Vector Ecology (Indian Region) and ICMR - National Institute of Malaria Research, FU, Goa I N D E X S.No. Name of the Delegate Page No. S.No. Name of the Delegate Page No. 1 A. N. Anoopkumar 45 42 Narayani Prasad Kar 50 2 Agenor Mafra-Neto 40 43 Naren babu N 63 3 Ajeet Kumar Mohanty 72 44 Naveen Rai Tuli 10-11 4 Alex Eapen 17 45 Neil Lobo 23 5 Algimantas Paulauskas 33 46 Nidhish G 65 6 Aneesh Embalil Mathachan 46 47 Norbert Becker 12 7 Aneesh Embalil Mathachan 28 48 O.P. Singh 78 8 Anju Viswan K 64 49 P. K. Rajagopalan 2-9 9 Ankita Sindhania 62 50 P. K. Sumodan 30 10 Ashwani Kumar 25 51 Paulo F. P. Pimenta 27 11 Ayyadevera Rambabu 29 52 Poonam Singh 90 12 Bhavana Gupta 43 53 Pradeep Kumar Shrivastava 20 13 Charles Reuben Desouza 89 54 R. S. Sharma 22 14 Dan Kline 37 55 R.K. Dasgupta 21 15 Deepa Jha 61 56 Rajendra Thapar 76 16 Deeparani K. Prabhu 68 57 Rajnikant Dixit 74 17 Devanathan Sukumaran 82 58 Rajpal Singh Yadav 1 18 Devi Shankar Suman 16 59 Raju Parulkar 84 19 Farah Ishtiaq 36 60 Rakhi Dhawan 73 20 Gourav Dey 88 61 Ramesh C Dhiman 32 21 Gunjan Sharma 86 62 Ranjana Rani 42 22 Hanno Schmidt 18 63 Roop Kumari 19 23 Hemachandra Bhovi 75 64 S. R. Pandian 49 24 Hemanth Kumar 53 65 Sajal Bhattacharya 31 25 Jagbir Singh 34 66 Sam Siao Jing 77 26 Jitender Gawade 83 67 Sanchita Bhattacharaya 56 27 John E.
    [Show full text]
  • Place De La Biologie Moléculaire Dans L'épidémiologie, Le Diagnostic Et L'évaluation De La Chimiorésistance Du Paludi
    Place de la biologie moléculaire dans l’épidémiologie, le diagnostic et l’évaluation de la chimiorésistance du paludisme en République Démocratique du Congo Dieudonné Mvumbi Makaba, MD, MSc. Département des Sciences de Base Faculté de Médecine Université de Kinshasa Thèse soutenue et défendue publiquement en vue de l'obtention du grade de Docteur en Sciences Biomédicales (PhD) Promoteur: Co-promoteur: Marie-Pierre Hayette, PhD Jean-Marie Kayembe, PhD Ulg Unikin Thèse Place de la biologie moléculaire dans l’épidémiologie, le diagnostic et l’évaluation de la chimiorésistance du paludisme en République Démocratique du Congo Par Dieudonné Mvumbi Makaba Présentée et soutenue publiquement en vue de l'obtention du grade de Docteur en Sciences Biomédicales (PhD) Le 11 février 2017 Composition du Jury : 1. Professeur Marie-Pierre Hayette, Université de Liège (promoteur) 2. Professeur Jean-Marie Kayembe, Université de Kinshasa (co-promoteur) 3. Professeur Hippolyte Situakibanza, Université de Kinshasa 4. Professeur Gauthier Mesia, Université de Kinshasa 5. Professeur Patrick De Mol, Université de Liège 6. Professeur Dieudonné Mumba, Université de Kinshasa 7. Professeur Prosper Lukusa, Katholieke Universiteit Leuven Université de Kinshasa Faculté de Médecine Département des Sciences de Base Service de Biologie Moléculaire Place de la biologie moléculaire dans l’épidémiologie, le diagnostic et l’évaluation de la chimiorésistance du paludisme en République Démocratique du Congo Dieudonné Mvumbi Makaba Promoteur Co-promoteur Marie-Pierre Hayette, PhD Jean-Marie Kayembe N., PhD A ma famille … Table des matières Liste des figures iii Liste des tableaux iv Liste des abréviations v Remerciements vi Résumé ix Introduction………………………………………………………….1 Partie I: Etat des connaissances……………………………………3 I.1.
    [Show full text]
  • The British Army's Contribution to Tropical Medicine
    ORIGINALREVIEW RESEARCH ClinicalClinical Medicine Medicine 2018 2017 Vol Vol 18, 17, No No 5: 6: 380–3 380–8 T h e B r i t i s h A r m y ’ s c o n t r i b u t i o n t o t r o p i c a l m e d i c i n e Authors: J o n a t h a n B l a i r T h o m a s H e r r o nA a n d J a m e s A l e x a n d e r T h o m a s D u n b a r B general to the forces), was the British Army’s first major contributor Infectious disease has burdened European armies since the 3 Crusades. Beginning in the 18th century, therefore, the British to tropical medicine. He lived in the 18th century when many Army has instituted novel methods for the diagnosis, prevention more soldiers died from infections than were killed in battle. Pringle and treatment of tropical diseases. Many of the diseases that observed the poor living conditions of the army and documented are humanity’s biggest killers were characterised by medical the resultant disease, particularly dysentery (then known as bloody ABSTRACT officers and the acceptance of germ theory heralded a golden flux). Sanitation was non-existent and soldiers defecated outside era of discovery and development. Luminaries of tropical their own tents. Pringle linked hygiene and dysentery, thereby medicine including Bruce, Wright, Leishman and Ross firmly contradicting the accepted ‘four humours’ theory of the day.
    [Show full text]
  • Medical Immunology.Pdf
    Page i Introduction to Medical Immunology Fourth Edition Edited by Gabriel Virella Medical University of South Carolina Charleston, South Carolina MARCEL DEKKER, INC. NEW YORK • BASEL • HONG KONG Page ii Library of Congress Cataloging-in-Publication Data Introduction to medical immunology / edited by Gabriel Virella. — 4th ed. p. cm. Includes bibliographical references and index. ISBN 0-8247-9897-X (hardcover : alk. paper) 1. Clinical immunology. 2. Immunology. I. Virella, Gabriel. [DNLM: 1. Immunity. 2. Immunologic Diseases. QW 504 I6286 1997] RC582.I59 1997 616.07'9—dc21 DNLM/DLC for Library of Congress 97-22373 CIP The publisher offers discounts on this book when ordered in bulk quantities. For more information, write to Special Sales/Professional Marketing at the address below. This book is printed on acid-free paper. Copyright © 1998 by MARCEL DEKKER, INC. All Rights Reserved. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval system, without permission in writing from the publisher. MARCEL DEKKER, INC. 270 Madison Avenue, New York, New York 10016 http://www.dekker.com Current printing (last digit): 10 9 8 7 6 5 4 3 2 1 PRINTED IN THE UNITED STATES OF AMERICA Page iii PREFACE Ten years after the publication of the first edition of Introduction to Medical Immunology, the ideal immunology textbook continues to be a very elusive target. The discipline continues to grow at a brisk pace, and the concepts tend to become obsolete as quickly as we put them in writing.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,191,108 B1 Rodkey Et Al
    USOO619 1108B1 (12) United States Patent (10) Patent No.: US 6,191,108 B1 Rodkey et al. (45) Date of Patent: Feb. 20, 2001 (54) RH BLOOD GROUPANTIGEN Moore et al., “Evaluation of monoclonal anti-Rh antibodies COMPOSITIONS AND METHODS OF USE as reagents for blood grouping and for the identification of (76) Inventors: L. Scott Rodkey, 6234 Yarwell, red cell membrane components associated with Rh antigen Houston, TX (US) 77096; Marwan A. activity,” Revue Francaise de Transfusion et Immuno-hé Yared; Kenneth J. Moise, Jr., both of matologie, 31(2):141-144, 1988. 4234 Tennyson, Houston, TX (US) 77005 Paradis et al., “Protective Effect of the Membrane Skeleton (*) Notice: Under 35 U.S.C. 154(b), the term of this on the Immunologic Reactivity of the Human Red Cell patent shall be extended for 0 days. Rho(D) Antigen,” J. Immunol., 137:240–244, 1986. Plapp et al., “Partial Purification of Rh(D) Antigen from Rh (21) Appl. No.: 09/164,789 Positive and Negative Erythrocytes,” Proc. Natl. Acad. Sci. (22) Filed: Oct. 1, 1998 USA, 76:2964-2968, 1979. Related U.S. Application Data Yokoi et al. “Isolation and Purification of Rh(D) Antigen of Human Erythrocyte Membrane and Its Serological Prop 62) DivisiVision off application No.NO. 08/715,173,f3, filedilled On Sep. 17If, 1996, now Pat. No. 5,840,585. erty,’” J. Exp. Med., 141:143–154, 1983. (51) Int. Cl." ..................................................... A61K 38/00 Foreign Search Report dated Dec. 2, 1997. (52) U.S. Cl. ............................................... 514/12; 530/380 (58) Field of Search ................................ 514/12; 530/380 Oellerich M., “Enzyme-Immunoassay: A Review,” J.
    [Show full text]
  • NCDC Introduction 2017
    National CentreNCDC for Disease Control -An Introduction NATIONAL CENTRE FOR DISEASE CONTROL (NCDC) AN INTRODUCTION Directorate General of Health Services Ministry of Health and Family Welfare Government of India July 2017 www.ncdc.gov.in Published by: Director, NCDC Compiled by: Team Library Design and Layout by: Avnesh Sharma National Centre for Disease Control – An Introduction 2017 ©National Centre for Disease Control CONTENTS Introduction 1 Organisation 2 Functions 3 Upgradation 6 National Health Programme and new initiatives 7 Central library 11 Branches 17 Major achievements 19 List of Directors 23 Contact Information: Headquarters 24 Contact Information: Branches 25 Organizational Chart 26 Upgraded NCDC Chart 27 INTRODUCTION e National Centre for Disease Control (NCDC) had its origin in Central Malaria Bureau, established at Kasauli (Himachal Pradesh) in 1909, which aer expansion was renamed in 1927 as the Malaria Survey of India to cater the need for malaria control in British India. e organization was shied to Delhi at its present location at 22-Shamnath Marg, Civil Lines in 1938 which was earlier occupied by Commander-in-Chief of Indian Army of that time and called as the Malaria Institute of India (MII) spread out in 13 acre area. e headquarters of the Directorate of National Vector Borne Disease Control Programme (NVBDCP) is also located in the same campus. In view of the drastic reduction achieved in the incidence of malaria in independent India under National Malaria Control Programme (NMCP) and National Malaria Eradication Programme (NMEP) during 1953-1963, Government of India decided to reorganize and expand the activities of the Institute to cover other communicable diseases.
    [Show full text]
  • A Review: the Duffy Blood Group System
    A review: the Duffy blood group system K.M. BEATTIE In 1950, two reports described an antibody that had neuraminidase. On the other hand, Fy3, Fy4, and Fy5 been found during the investigation of a hemolytic are not affected. Reactionswith purified trypsin show transfusion reaction in the serum of a 43-year-old man that the Fysup(a) antigen is unaffected and Fy sup(b) is only slightly suffering from hemophilia. 1,2 After the unidentified reduced in strength; Fy3 and Fy6 are slightly enhanced. antibody had been separated from the anti-D, anti-A, The trypsin most commonly used by blood bankers and anti-Bin his serum, it was tested against the blood is a crude preparation that is contaminated with chymo- of 205 unrelated English adults; 64.9 percent were ,agglu- trypsin; therefore, results obtained with that product tinated. With the permission of the patient, the new would approximate those resulting from chymotrypsin blood group system was named Duffy The antigen was treatment. designated as Fysup(a), the gene responsible for it, Fy sup(a), and Inactivation of Fy determinants is such that they are its hypothetical allele, Fysup(b). Anti-Fysup(b) was reported the no longer capable of adsorbing their antithetical anti- following year in the serum of a German woman who bodies. This is not due to the removal of sialic acid but had been pregnant three times but not transfused.sup(3) probably represents proteolytic action on cell membrane Four years later, Fy(a-b-) was reported to be the proteins. Fy(a-b-) red cells are not sialic acid deficient most common phenotype in American blacks.sup(4) and their electrophoretic mobility is normal.
    [Show full text]
  • PDAAF117B1.Pdf
    DECONTROLLED PER MEMORANDUM TO REFERENCE CENTER FROM FLOYD R. SPEARS, AFR/EMS DATED AUG. 2, 1977. (SEE ENCLOSED MEMO.) m P let am W4u1g UNI N ITATU1 OOVuNUT Memorandum TO : Reference Centr, b. JoFne Paukar DAIR: August 2. 1977 Waiur: Declassification of A.I.D. Documents This memorandum addresses the following A.I.D. documents: a. Measles Control and Smallpox Eradication Program dated Jan. 5, 1970 b. CAP on Trans-Cameroon Railroad (Phase II) c. Mali -- Proposal and Recommendations on Veterinary Laboratory d. CAP -- Liberia - Improvements of Roberts International Airport, Phase El (Construction) e. CAP -- Swaziland -- Agricultural Development Loan f. CAP -- Ethiopia Malaria Eradication -- Phase I g. CAP -- Somalia -- Mogadiscio Iater Supply h. CAP -- Tanzania -- Agricultural Projects Support i. CAP - TANZAM Highway Phase III J. CAP -- Uganda - Livestock Developmnt The above listed documents have been reviewed by appropriate personnel staff assigned to Africa Bureau to determine if these should documents be declassified. Based on this review, no Justifications been identified have for the continued classification of these documents. Therefore, this memorandum hereby authorizes the declassification of all documents listed. It Iq U.S. sauw, -am ?ut, SaMq lm SPARTW OF STATE AGUC" Or IIOR1 ATIO .ALIIV MENT Washington, D.C. 20523 L USE AID-3lXC/P-570' May 22, 1967 MW4ORANDUM FOR THE £VELOPMENT LOAN COMMITTEE SUBJECT: Ethiopia - Malaria Eradication - Phase I Attached for you: review are the recommendations for authorization cf a loan in an amount not to exceed $5,80,OOO to the Government of Ethiopia to assist in finanning the foreign exchange costs and local costs of a malaria eradication program in Ethiopia.
    [Show full text]
  • Journal 2Nd Issue LVIII 3
    JOURNAL OF THE ASIATIC SOCIETY VOLUME LXII No. 4 2020 Special Issue on History of Diseases and Medicine in India and Beyond THE ASIATIC SOCIETY 1 PARK STREET KOLKATA 16 © The Asiatic Society ISSN 0368-3308 Edited and published by Dr. Satyabrata Chakrabarti General Secretary The Asiatic Society 1 Park Street Kolkata 700 016 Published in January 2021 Printed at Desktop Printers 3A, Garstin Place, 4th Floor Kolkata 700 001 Price : 400 (Complete vol. of four nos.) CONTENTS Introduction to the volume ... ... v ARTICLES Social Perceptions of Diseases in Early India Nayana Sharma Mukherjee ... ... 1 Prameha: Conception of a Disease in Ancient Äyurvedic Texts Nupur Dasgupta ... ... 17 An Illustrated Ophthalmic Register of an Arogyasala in Serfoji II’s (1798-1832) Thanjavur : An Emblem of Plural Medical Practices Tutul Chakravarti and Ranabir Chakravarti ... 49 Environmental Change, Health and Disease in Bengal’s Western Frontier : Chotanagpur between 1800-1950s Sanjukta Das Gupta ... ... 67 Pollution, Public Health and the People of Calcutta: The Nineteenth Century Mahua Sarkar ... ... 85 “The Child to Avoid Fire; by Allowing it to Burn Itself”: Public Health and Tuberculosis in South India, 1898-1947 B. Eswara Rao ... ... 121 Smallpox and Children in Colonial Bengal : Revisiting a Virulent Epidemic Sujata Mukherjee and Nilanjana Basu ... 147 Science and Philanthropy in a Colonial State : Reviewing the Intervention of Rockefeller Foundation in Bengal Arabinda Samanta ... ... 163 ( iv ) Trauma of Tuberculosis : Medical Intervention, Containment and Popular Response in Post-independence India Achintya Kumar Dutta ... ... 179 Government Policies and Medical Treatment in three Ayurvedic Hospitals in Kolkata (1970-2010) Sutapa Saha Mitra ... ... 205 Medical History : British India, the Dutch Indies and Beyond Deepak Kumar ..
    [Show full text]
  • Rbgp-An-International-Study.Pdf
    IMMUNOHEMATOLOGY Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study Axel Seltsam,1 Franz Wagner,1 Mark Lambert,2 Tom Bullock,3 Nicole Thornton,3 Erwin A. Scharberg,4 Daniela Grueger,5 Clemens Schneeweiss,5 and Rainer Blasczyk6 n current blood transfusion practice, red blood cell BACKGROUND: Alloantibodies to high-prevalence red (RBC) antibodies are identified using panels of blood cell (RBC) antigens are not easily identified by human RBCs pretyped for the most common blood routine serologic techniques. This multicenter study was group antigens. The specificity of a given antibody is conducted to test the effectiveness of recombinant Iidentified based on the pattern of reactivity observed blood group proteins (rBGPs) at regional and interna- when serum is tested with the cell panel. Since many anti- tional RBC reference laboratories. gens are expressed on RBCs, antibody identification in STUDY DESIGN AND METHODS: Single or mixed RBC-based assays relies on nonreactivity of an antibody soluble rBGPs (Lu, Yt, Kn, JMH, Sc, Rg, Ch, Do, and with panel cells lacking the corresponding antigen. This Cr) were assessed for their ability to inhibit the reactiv- method of antibody identification is challenged if autoan- ity of antibodies to specific antigens. Initially, the effect tibodies, multiple antibodies, or antibodies to high- of rBGPs was validated by testing panels of well- prevalence antigens are present. In such cases, rare characterized patient serum samples containing antisera and cells as well as specially trained personnel antibodies to high-prevalence antigens in the hemagglu- not available to routine laboratories are required for tination inhibition assay.
    [Show full text]